Calypte Biomedical Corp (fka CBMC)

[Ceniises]

In reply to: Ceniises who wrote msg# 3947 Date:7/16/2007 12:42:56 PM
Post #of 3951

"Gale has done everything he stated he would do, within his control. The objectives outlined since he took over the helm have been met and he kept his promises to investors."


Absolute Hogwash Ceniises.

Roger Gale said.

Would hire a qualified CEO with medical experience in 3-6 months. .......7 months later he hired himself with NO medical experience.

GALE MADE THAT STATEMENT WHEN HE ACTED AS INTERIM PRESIDENT, AN IMPORTANT POINT YOU NEGLECTED TO MENTION. AT THAT TIME, THERE WAS AN INTENT TO HIRE SOMEONE ELSE AS HE WAS CHAIRMAN, CEO OF A MAJOR TELECOMMUNICATIONS COMPANY IN ENGLAND. HE HAD NO INTENTION ON BECOMING PRESIDENT. SECONDLY, YOU WERE WRONG WHEN YOU STATED HE HIRED HIMSELF, A BOARD OF DIRECTORS DID. THE ABOVE STATEMENT WAS A DISTORTION ON YOUR BEHALF.

AS PROVEN DURING THE PAST COUPLE OF MONTHS, CALYPTE DID NOT NEED SOMEONE WITH MEDICAL EXPERIENCE, THEY NEEDED A GOOD BUSINESSMAN WITH GLOBAL EXPERIENCE. GALE FIT THAT BILL. HE HAD EXPERIENCE IN THE REGION, WORKED FOR THE WORLD BANK, WORKED IN THE INSURANCE INDUSTRY AND FOUNDED AND MANAGED HIS OWN COMPANY, WHICH WAS A PROFITABLE, PRIVATELY OWNED COMPANY. PROFITABLE ENOUGH TO BE SOLD TO A MAJOR CONGLOMERATION.

Marr could fund Calypte to profitability with no further dilution

PLEASE PROVIDE A SPECIFIC QUOTE. ALL TRANSCRIPTS ARE ONLINE AND I HAVE BEEN UNABLE TO FIND THAT PARTICULAR STATEMENT YOU HAVE QUOTED. I RECALL HIM STATING FINANCING WOULD BE A SORT OF "PIPE FINANCING." 5/22/06 SEC DOCUMENT FILING OF CONFERENCE CALL, 4/5/07, CONFERENCE CALL, 5/07 FIRST QUARTER CONFERENCE CALL,


MARR COULD DO SO--HE DEFINITELY HAS THE RESOURCES. HOWEVER MARR IS NOT CURRENTLY FUNDING CALYPTE. OTHER INVESTORS ARE COMING IN TO FUND CALYPTE. IN THE FUTURE, WITH CHINA APPROVAL, IT COULD VERY WELL BE FUNDED TO PROFITABILITY WITH NO FURTHER DILUTION IF THEY SELL THE QUANTITY THEY ARE PROJECTING. FURTHER, THE TYPE OF FINANCING IS DEPENDENT UPON THE COMPANY OBJECTIVES. IF IT CHOSE TO SIMPLY SELL TESTS IN ASIA, THE MIDEAST AND AFRICA, THEN THIS IS ALTOGETHER TRUE. FINALLY, WHAT YOU HAVE FAILED TO TAKE INTO CONSIDERATION IS THE CHINA DELAY, TOTALLY OUT OF CONTROL OF GALE AND OTHERS. AND MY STATEMENT WAS HE HAS DONE EVERYTHING HE SAID HE WOULD WITHIN HIS CONTROL.....

... Stock has diluted immensely since then. I believe the outstanding shares have doubled in less than 2 years...


Calypte would be profitable by late 2006. WRONG
that was changed to Calypte would be profitable by late 2007 . Now that is changed to mid 2008 "maybe sooner, maybe later."

AGAIN, MY COMMENT WAS HE HAS UPHELD EVERY PROMISE THAT WAS WITHIN HIS CONTROL. PROFITABILITY WAS BASED UPON CHINA APPROVAL, WHICH WAS DELAYED DUE TO CHINA BUREAUCRATIC PROCESS NOT ROGER GALE AND CALYPTE ADMINISTRATIVE ERROR OR NEGLIGENCE AS YOU ARE ATTEMPTING TO TRY TO PORTRAY.

He had gotten 2 investors to invest 3 million dollars in company ....... They reneged on over 2.5 million of that investment and Roger no longer mentions it.....

HE IS NOT RESPONSIBLE FOR THE ACTIONS OF OTHERS, HOWEVER WHEN OTHERS DID COMMIT ACTIONS WHICH ARE DETRIMENTAL TO THE COMPANY, HE IMMEDIATELY RESOLVED THE ISSUE AND FOUND ALTERNATIVE RESOLUTION. AGAIN, SOMETHING THAT WAS NOT WITHIN HIS CONTROL...AS I STATED HE HAS UPHELD EVERY PROMISE THAT WAS WITHIN HIS CONTROL AND IN THIS CASE, RESOLVED THE PROBLEM BEAUTIFULLY. THAT WAS NOT A BREACH OF PROMISE AS YOU HAVE DISTORTED IT TO BE.

He got a 1,000,000 test kit commitment from Mineseeker for first year ..... They actually ordered 3.55% of the commitment.

ON JULY 13, 2007, ONE YEAR AGO, MINESEEKER ORDERED 35,500 TESTS, WHICH WAS THE FIRST OF 1,000,000 TESTS INTENDED TO BE PURCHASED DURING THE NEXT YEAR. THE P.R.s SPECIFICALLY REPRESENTED IT AS SUCH. AS STATED IN THE PRESS RELEASE, THERE WAS AN INTENT, NOT A COMMITMENT AS YOU HAVE DISTORTED IT TO BE. FINALLY, IT SHOULD BE NOTED ONLY TWO QUARTERS PERFORMANCE HAS BEEN REPORTED SINCE THAT TIME AND THERE ARE STILL TWO MORE QUARTERS WHERE THIS MAY OR MAY NOT OCCUR. THE POINT IS NOBODY KNOWS, NOT YOU, NOT ME, ONLY CALYPTE. PART OF YOUR DISTORTION IS PLAYING UPON HISTORICAL INFORMATION, MAKING IT APPEAR AS IF IT IS OCCURRING TODAY, WHEN IN FACT, REPORTING IS ALWAYS BEHIND APPROXIMATELY TWO MONTHS. http://phx.corporate-ir.net/phoenix.zhtml?c=97535&p=irol-newsArticle&ID=881886&highlight

UAE ane Russia were each projected at 500,000+ test kits in first year. No reorders of intial stocking order of 100,000 and 25,000 kits in 2006.

A YEAR HAS NOT PASSED SINCE THE APPROVAL OF RUSSIA, YET ANOTHER DISTORTION. THE YEAR WILL BE UP AND REPORTED IN FEBRUARY OF 2008. TO DATE, THERE HAS ONLY BEEN SIX MONTHS OF REPORTING. THIS IS ANOTHER DISTORTION OF YOU PLAYING WITH REPORTING DATES AND QUARTERLY REPORTS. THE ONLY REFERENCE TO 500,000 TESTS WAS MADE BY VLADIMIR SAVELIV, MANAGING DIRECTOR OF ORDYNKA INVESTMENTS LIMITED. HE STATED ON 12/12/06, SEVEN MONTHS AGO, "WE INTEND TO DELIVER NO LESS THAN 500,000 TESTS TO THE RUSSIAN FEDERATION OVER THE NEXT 12 MONTHS AND ARE
CONFIDENT THAT THE NEED FOR THESE PRODUCTS CAN BE GREATER THAN THIS." MR. SAVELIV IS A DISTRIBUTOR, NOT AN EMPLOYEE OF CALYPTE, NOR AN AKA FOR MR. GALE. THE FINAL FIGURES WOULD NOT BE REPORTED UNTIL APRIL OF 2008, IF THIS OBJECTIVE WAS MET. THEREFORE, YOUR STATEMENT IS VERY DISTORTED AND UNTRUE, AS YOU ATTRIBUTED THIS COMMENT TO MR. GALE.

THE UAE WAS APPROVED FOR OVER THE COUNTER SALES ON 1/19/2006. ON 4/5/07, THE FOLLOWING WAS ANNOUNCED DURING THE CONFERENCE CALL: "SALES OF OUR AWARE HIV ORAL FLUID RAPID TEST WERE $278,000 IN THE FOURTH QUARTER OF 2006 COMPARED WITH $19,000 IN THE FOURTH QUARTER OF 2005, AN INCREASE OF OVER 14 TIMES. AS WE INDICATED IN OUR LAST CONFERENCE CALL, THIS IS PRIMARILY THE RESULT OF THE SALE OF THE OTC VERSION OF OUR ORAL FLUID TEST TO OUR DISTRIBUTOR IN THE MIDDLE EAST FOR SALE IN THE UAE. FOR THE YEAR, OUR AWARE RAPID TEST SALES TOTALED $306,000 IN 2006, COMPARED WITH $21,000 IN 2005, THE INCREASE REFLECTING BOTH THE FOURTH QUARTER 2006 SALE TO OUR MIDDLE EAST DISTRIBUTOR AND SALES TO OUR SOUTH AFRICAN DISTRIBUTOR THROUGHOUT 2006." THIS REFLECTS $281,000 IN SALES TO THE UAE AND AFRICA DURING 2006. THE FIRST SUBSTANTIAL ORDER WAS RECEIVED PRIOR TO 8/9/06 OF ONE HUNDRED THOUSAND TESTS TO THE UAE.

NOWHERE CAN I FIND A PROMISE OR A STATEMENT BY ROGER GALE THAT CALYPTE WOULD SELL FIVE HUNDRED THOUSAND TESTS IN THE EACH OF THE COUNTRIES OF THE UAE AND RUSSIA, DURING THE FIRST YEAR, FOLLOWING APPROVAL, AND MADE BY MR. GALE. PLEASE CITE THE SOURCE OF YOUR COMMENTS.

Hogwash Cenisses. Roger Gale has a pathetic record on meeting his commitments, as shown above. Please list all commitments he has made that have been successful.

Oh yeah they also had to borrow $ 65,000 from an employee to buy materials to make BED incidence tests in first quarter. How pathetic is that.

EVIDENTLY, THE LOAN PAID OFF AND CALYPTE IS NOT ONLY PREVAILING BUT SOARING, IN OPPOSTION TO YOUR PREDICTIONS AND DISTORTIONS.

WITHOUT THE CITATIONS TO SUPPORT YOUR STATEMENTS, YOUR COMMENTS WILL HAVE TO BE VIEWED AS GROSS MISREPRESENTATIONS, RIDDLED WITH BLATANT INACCURACIES. IT WOULD BEHOOVE YOU TO QUOTE THE CITATIONS AND STATE THE SOURCE FOR YOUR COMMENTS.

FINALLY, THE INDIA APPROVAL CAME THROUGH EXACTLY AS STATED BY GALE, IN FACT, AHEAD OF TIME. THE UAE APPROVAL CAME THROUGH EXACTLY AS STATED BY GALE. THE COMPANY HAS FOUND NEW HEADQUARTERS FOR THE U.S. EXPANSION EXACTLY AS STATED BY GALE. THE BED INCIDENT TESTS ARE AGAIN RAMPING UP, EXACTLY AS STATED BY GALE. FINANCING WAS FOUND, EXACTLY AS STATED BY GALE. APPROVALS CAME ABOUT, EXACTLY AS STATED BY GALE.

THE ONLY DELAYS HAVE BEEN FROM OUTSIDE FORCES, OVER WHICH NOBODY HAS CONTROL, AS I HAVE STATED.